Matthias H.
- Country
- Germany
- Department
- NA
Research Overview
- A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study)
- A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-88545223 in Participants with Active Psoriatic Arthritis
- Efficacy and Safety of Lebrikizumab in Adults With Nummular Dermatitis Inadequately Controlled by Topical Corticosteroids: A Phase 3, Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 226 of 455 partner sites.
Specializations
Dermatological Conditions
This investigator specializes in treating various forms of dermatological disorders, with particular emphasis on chronic inflammatory skin conditions.
- Plaque Psoriasis
- Atopic Dermatitis
- Prurigo Nodularis
- Psoriatic Arthritis
The research encompasses both localized and systemic manifestations of these conditions.
Treatment Approaches
The investigator focuses on evaluating novel therapeutic interventions for dermatological conditions, including both traditional and innovative treatment methods.
- Biologic Therapies
- JAK Inhibitors
- Topical Treatments
- Long-term Management Strategies
Special attention is given to treatment-resistant cases and long-term therapeutic outcomes.
Patient Populations
The investigator works with diverse patient groups affected by dermatological conditions, focusing on varying disease severities and age ranges.
- Adolescent Patients
- Adult Patients
- Treatment-Naive Individuals
- Previously Treated Patients
Research includes special attention to moderate-to-severe disease manifestations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.